Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation: a case report

Tian-Ming Xuan; Xing-Xiang Wang; Xiang-Yuan Pu; Wei-Li Han; Xiao-Gang Guo

doi:10.1631/jzus.B2000182

Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation: a case report

J Zhejiang Univ Sci B. 2020 May;21(5):411-415. doi: 10.1631/jzus.B2000182. Epub 2020 May 9.

Authors

Tian-Ming Xuan¹, Xing-Xiang Wang¹, Xiang-Yuan Pu¹, Wei-Li Han², Xiao-Gang Guo¹

Affiliations

¹ Department of Cardiology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
² Department of Lung Transplantation, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.

Abstract

We present an unusual case of a patient with bilateral-lung transplantation due to severe coronavirus disease 2019 (COVID-19), who subsequently suffered complications with acute myocardial infarction and underwent primary percutaneous coronary intervention (PCI).

Keywords: Coronavirus disease 2019 (COVID-19); Lung Transplantation; ST-segment elevation myocardial infarction; Percutaneous coronary revascularization.

Publication types

Case Reports

MeSH terms

Aged
Betacoronavirus
COVID-19
China
Coronavirus Infections / complications*
Humans
Lung Diseases / surgery
Lung Diseases / virology*
Lung Transplantation*
Male
Pandemics
Percutaneous Coronary Intervention*
Pneumonia, Viral / complications*
SARS-CoV-2
ST Elevation Myocardial Infarction / surgery*
ST Elevation Myocardial Infarction / virology